CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.
Hoffmann D, Corleis B, Rauch S, Roth N, Mühe J, Halwe NJ, Ulrich L, Fricke C, Schön J, Kraft A, Breithaupt A, Wernike K, Michelitsch A, Sick F, Wylezich C, Hoffmann B, Thran M, Thess A, Mueller SO, Mettenleiter TC, Petsch B, Dorhoi A, Beer M.
Hoffmann D, et al. Among authors: petsch b.
Nat Commun. 2021 Jun 30;12(1):4048. doi: 10.1038/s41467-021-24339-7.
Nat Commun. 2021.
PMID: 34193869
Free PMC article.